Collaboration will provide biopharmaceutical companies access to Guardant Health's broad portfolio of cancer tests to help advance drug development programs and their clinical trials
SINGAPORE, July 6,
Barclays analyst Pablo Monsivais downgrades Gol Intelligent Airlines (NYSE:GOL) from Overweight to Equal-Weight and lowers the price target from $9 to $4.
The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech
Procurement Agreement Following a New Tender Won from an International Organization Operating Principally in Latin America
Product Supply Expected During